Since signalling pathways such as Akt and ERK directly modify Bcl-2 and beclin-1, the resulting phospho-patterns may predict the tumour’s responsiveness to upstream kinase inhibitors [70,71]. The gene discussed is BECN1; the disease is neoplasm.